# cePolyTregs in Islet Transplantation

> **NCT05349591** · PHASE1 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Diabetes type1

## Interventions

- **BIOLOGICAL:** cePolytreg

## Key facts

- **NCT ID:** NCT05349591
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08-15
- **Primary completion:** 2025-05-22
- **Final completion:** 2025-05-22
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to feasibility challenges and following mutual agreement by JDRF CCTN and the Principal Investigator for Statement of Work 4 (SOW4), the study conducted by Dr. James Shapiro has been withdrawn/terminated.
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05349591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05349591, "cePolyTregs in Islet Transplantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05349591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*